SunTrust Banks Reiterates $40.00 Price Target for Envision Healthcare (EVHC)

Envision Healthcare (NYSE:EVHC) received a $40.00 price target from stock analysts at SunTrust Banks in a research report issued on Thursday. The firm presently has a “buy” rating on the stock. SunTrust Banks’ price target would suggest a potential upside of 15.87% from the stock’s previous close.

Several other equities analysts have also weighed in on the stock. Jefferies Group set a $71.00 price objective on shares of Envision Healthcare and gave the company a “buy” rating in a report on Wednesday, November 1st. KeyCorp set a $67.00 price objective on shares of Envision Healthcare and gave the company a “buy” rating in a report on Wednesday, November 1st. Cantor Fitzgerald restated a “hold” rating and issued a $30.00 price objective on shares of Envision Healthcare in a report on Tuesday, November 14th. Canaccord Genuity restated a “buy” rating and issued a $32.00 price objective (down from $68.00) on shares of Envision Healthcare in a report on Thursday, November 2nd. Finally, Bank of America cut their price objective on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, October 9th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $43.25.

Envision Healthcare (NYSE:EVHC) opened at $34.52 on Thursday. Envision Healthcare has a 12-month low of $23.77 and a 12-month high of $73.00. The stock has a market cap of $3,943.41, a P/E ratio of 10.07, a PEG ratio of 1.06 and a beta of 0.57. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01.

Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. During the same quarter in the prior year, the company earned $1.13 earnings per share. The company’s quarterly revenue was up 142.0% on a year-over-year basis. research analysts anticipate that Envision Healthcare will post 2.56 EPS for the current fiscal year.

Envision Healthcare announced that its Board of Directors has approved a stock buyback plan on Monday, September 18th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to reacquire up to 4.5% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its shares are undervalued.

A number of large investors have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in Envision Healthcare by 1.8% in the second quarter. Vanguard Group Inc. now owns 11,471,402 shares of the company’s stock valued at $718,912,000 after purchasing an additional 204,584 shares in the last quarter. BlackRock Inc. increased its stake in Envision Healthcare by 2.1% in the second quarter. BlackRock Inc. now owns 7,345,283 shares of the company’s stock valued at $460,330,000 after purchasing an additional 147,652 shares in the last quarter. Maverick Capital Ltd. increased its stake in Envision Healthcare by 66.2% in the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock valued at $319,197,000 after purchasing an additional 2,028,026 shares in the last quarter. Janus Henderson Group PLC increased its stake in Envision Healthcare by 0.3% in the third quarter. Janus Henderson Group PLC now owns 3,958,329 shares of the company’s stock valued at $177,927,000 after purchasing an additional 13,242 shares in the last quarter. Finally, OZ Management LP bought a new stake in Envision Healthcare in the third quarter valued at approximately $131,987,000.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The legal version of this story can be viewed at https://www.com-unik.info/2017/12/22/suntrust-banks-reiterates-40-00-price-target-for-envision-healthcare-evhc.html.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit